Simplifying Complex Illness
RTHM connects you with a care team specializing in Long COVID and ME/CFS that provides access to a broad range of therapies based on the latest research.
RTHM connects you with a care team specializing in Long COVID and ME/CFS that provides access to a broad range of therapies based on the latest research.
All RTHM clinicians have completed a 100+ hour training program specifically tailored to Long COVID, ME/CFS, and commonly co-occuring conditions. An expert panel of multiple RTHM clinicians also reviews your case periodically.
Patients go through a comprehensive workup including over 300 biomarkers backed by the latest research to ensure no rock is left unturned to get you back into your rhythm.
Our care navigators will partner with you throughout your care journey to help quarterback your care so you have more time and energy to do what you love.
Symptoms and vitals fluctuate over time - wearables and daily symptom tracking allows us to measure how your physiology is changing over time in response to treatments.
We listen and work collaboratively with you in your care. Every symptom and treatment tried by a patient provides clues in their journey to getting back to health. That is why we aggregate our patients' experiences and deploy the learnings through our treatment pathways. At RTHM, you benefit from the latest medical research and from the experience of other patients similar to you. We leverage the latest science and the data from all of our patients to find the most effective treatment course in the least amount of time.
A shorter path to effective treatment: in complex illness there are often several underlying health issues that need to be addressed using multiple treatments. We learn from what has worked from patients similar to you to efficiently find the best combination of treatments for you. We then measure your response to each treatment through vitals, labs and surveys and iterate until we find what works for you.
Complex illnesses such as Long COVID & ME/CFS are so challenging to treat because the mechanisms causing them are still being determined. Additionally, not every patient is the same. Through our partnership with patients, research labs and by investing in our own laboratory capabilities, we aim to advance science through discovering biomarkers to better understand, diagnose, and treat these illnesses.